{"SPADE_N_06814": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_06814", "Peptide Name": "Cilengitide, EMD 121974", "Source": "RGD Fibronectin", "Family": "", "Gene": "Not found", "Sequence": "RGDFX", "Sequence Length": 5, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:M21 (IC50 (Cilengitide inhibited integrin-mediated binding to vitronectin) =0.4 µM); UCLA-P3 (IC50 (Cilengitide inhibited integrin-mediated binding to vitronectin) =0.4 µM)", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Integrins αvβ3, αvβ5", "Linear/Cyclic": "Cyclic", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "Mix", "Structure Description": "Not found", "Formula": "C12H18N6O4", "Mass": 49184, "PI": 6.34, "Net Charge": 0, "Hydrophobicity": -1.68, "Half Life": "Mammalian:1 hourYeast:2 minE.coli:2 min", "Literature": [{"Title": "Nanomolar small molecule inhibitors for alphav(beta)6, alphav(beta)5, and alphav(beta)3 integrins", "Pubmed ID": "11855984", "Reference": "J Med Chem. 2002 Feb 28;45(5)1045-51", "Author": "Goodman SL, Hölzemann G, Sulyok GA, Kessler H.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=11855984"}], "Frequent Amino Acids": "DFG", "Absent Amino Acids": "ACEHIKLMNOPQSTUVWY", "Basic Residues": 1, "Acidic Residues": 1, "Hydrophobic Residues": 1, "Polar Residues": 1, "Positive Residues": 1, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05302", "Similarity": 1.0, "Sequence": "LDDDDDINDSSNWIKANPNLGVSINLDEMKEEWEKAKRTPAERGDFITKRFNIFANNDEMSFIDYPTLQKK"}, {"SPADE_ID": "SPADE_N_07334", "Similarity": 1.0, "Sequence": "KKKKKKNKKLQQRGD"}, {"SPADE_ID": "SPADE_N_13003", "Similarity": 1.0, "Sequence": "GRGDFINLKKLAKLKKIL"}]}}}